NeurATRIS is a French research infrastructure conceived to accelerate the translation of discoveries in basic research into medical innovations for the treatment of nervous system diseases. NeurATRIS brings together 5 hospitals and public research centers whose expertise and skills in neuroimaging, pharmacology and biotherapies are complementary and internationally renowned. NeurATRIS proposes a range of services and partnerships to all life science actors for the realization of projects dedicated to the development of diagnosis and therapies for neurological and neurodegenerative diseases (Parkinson's, Huntington's, Alzheimer's diseases and multiple sclerosis). NeurATRIS provides state-of-the-art platforms and complementary models (cells, animals) enabling the screening, the characterization, the evaluation and validation up to patients (phase II) of the most promising therapies: - High resolution neuroimaging (MRI, PET, SPECT, 3D histology, PET-MRI hybrid, cell imaging platform, etc.), - Functional assessment (spectroscopy, cognitive and motor behavior, electrophysiology, etc.), - Neurodegenerative disease models (cell cultures, rodents, non-human primates, etc.), - Therapeutic approaches (gene and cell therapies, functional neurosurgery, largest patient cohorts, human and animal bio-collections, etc.), In order to offer the most appropriate models and tools that meet your expectations and your therapeutic strategies, NeurATRIS experts are partners of choice to complete together your projects with tailor-made solutions.